Connecticut Wealth Management »

Tg Therapeutics shares owned by Connecticut Wealth Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Connecticut Wealth Management from 13F filings

Historical chart of Connecticut Wealth Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Connecticut Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Connecticut Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $475k 28k 17.08
2023-09-30 $232k 28k 8.36
2023-06-30 $690k 28k 24.84
2023-03-31 $418k 28k 15.04
2022-12-31 $329k 28k 11.83
2022-09-30 $164k 28k 5.90
2022-06-30 $118k 28k 4.25
2022-03-31 $195k 21k 9.51

More positions owned by Connecticut Wealth Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Core Msci Emkt (IEMG)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Connecticut Wealth Management

Top funds holding Tg Therapeutics

Vanguard Group
Darwin Global Management
Millennium Management
Wellington Management Company
Opaleye Management
Paradigm Biocapital Advisors
683 Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management
Norges Bank Investment Management
Marshall Wace
Gts Securities
Soleus Capital Management
Jane Street

View all funds holding Tg Therapeutics